Lewy bodies, a pathological hallmark of Parkinson's disease (PD), contain aggregated alpha-synuclein (aSyn), which is found in several modified forms and can be discovered phosphorylated, ubiquitinated and truncated. Aggregation-prone truncated species of aSyn caused by aberrant cleavage of this fibrillogenic protein are hypothesized to participate in its sequestration into inclusions subsequently leading to synaptic dysfunction and neuronal death. Here, we investigated the role of calpain cleavage of aSyn in vivo by generating two opposing mouse models. We crossed into human [A30P]aSyn transgenic (i) mice deficient for calpastatin, a calpain-specific inhibitor, thus enhancing calpain activity (SynCAST(2)) and (ii) mice overexpressing human calpastatin leading to reduced calpain activity (SynCAST(1)). As anticipated, a reduced calpain activity led to a decreased number of aSyn-positive aggregates, whereas loss of calpastatin led to increased truncation of aSyn in SynCAST(2). Furthermore, overexpression of calpastatin decreased astrogliosis and the calpaindependent degradation of synaptic proteins, potentially ameliorating the observed neuropathology in [A30P]aSyn and SynCAST(1) mice. Overall, our data further support a crucial role of calpains, particularly of calpain 1, in the pathogenesis of PD and in disease-associated aggregation of aSyn, indicating a therapeutic potential of calpain inhibition in PD.
INTRODUCTION
Parkinson's disease (PD) is a slowly progressive disorder caused by neuronal loss of dopaminergic neurons predominantly in the substantia nigra pars compacta (1, 2) . The neuropathological hallmark of PD is intracellular inclusions termed Lewy bodies (LB) that are mainly composed of alpha-Synuclein (aSyn) (2, 3) .
Increasing evidence strongly suggests that aSyn inclusions accumulate in a hierarchical pattern, reflecting vulnerability of distinct neuronal populations in the PD brain and initially * To whom correspondence should be addressed at: Institute of Medical Genetics and Applied Genomics, University of Tübingen, Calwerstrasse 3975-3989 doi:10.1093/hmg/ddu112 Advance Access published on March 11, 2014 affecting distinct nuclei in the brain stem spreading into cerebral cortical areas in advanced PD (4 -6) . Intracellularly, the formation of pathological aSyn depositions occurs by a multistep process, including a conformational change and the association of the misfolded protein into protofilaments and amyloid fibrils, forming the disease specific entity (7, 8) . Several studies have elucidated the role of different aSyn regions on fibrillation of aSyn. Whereas the N-terminus transforms into a helical conformation upon its binding to phospholipids (9, 10) , and the NAC domain was shown to form the core region of fibrils (11) , it appears that the acidic C-terminus, however, is not implicated in the observed fibrillation pathology. Instead, it preserves aSyn fibrillation by maintaining the unfolded structure of the monomeric form (12, 13) . Both, neutralization of the negative charge of the C-terminus via calcium (14) and the C-terminal truncation, were associated with an enhanced aggregation and fibrillation in vitro (15, 16) and in vivo (17) (18) (19) .
Several proteases are implicated in C-terminal truncation of aSyn subsequently leading to enhanced aggregation pathology. Among others, plasmin has a predominant role in cleavage of the N-terminal region (20) , and MMPs, neurosin, as well as cathepsin D cleave at several sites within aSyn (21) (22) (23) (24) . Further, C-terminal fragments of aSyn derived from the lysosomal enzyme cathepsin D are a main component of aSyn assemblies (25) .
Besides these proteases, calpains have been implicated in several neurodegenerative diseases, including PD (26) . Calpains are calcium-dependent proteases and play an essential role in numerous physiological cellular and neuronal functions (27) . Alterations in calcium homeostasis lead to pathological activation of calpains affecting negatively the function of several neuronal substrates such as aSyn, amyloid-beta and ataxin 3 (26) (27) (28) (29) . Pathological activation of calpains is also involved in synaptic dysfunction and may be critical to memory formation (27, 30, 31) .
Recently, it was shown that calpain 1, one of the major isoforms of the calpain family in the brain, cleaves aSyn in vitro: soluble aSyn is cleaved at amino acid 57, whereas the cleavage sites within fibrillar aSyn are predominantly located at the C-terminus at amino acids 114 and 122, promoting the co-assembly of soluble aSyn (32, 33) . Dufty et al. (3) showed that C-terminally calpain-cleaved aSyn is detectable in LB in brains of PD patients. The role of calpain in the pathogenesis of PD was supported through the inhibition of calpain in a mouse model, which prevents neuronal and behavioral deficits induced by the neurotoxin MPTP (34) . Additionally, overexpression of calpastatin, the endogenous specific inhibitor of calpain, was shown to reduce calpain activity and to protect from calcium-dependent neuronal excitotoxicity in transgenic mouse brain (30) . Vice versa, calpastatin depletion triggered excitotoxicity, importantly without affecting development, viability and synaptic plasticity under physiological (calcium) conditions in mice (35) .
Taking advantage of mice displaying an age-dependent aSyn pathology, including its presence as proteinase K (PK)-resistant and insoluble conformation (36-38), we investigated whether calpains are implicated in the aSyn induced pathogenesis of PD. Therefore, we crossed calpastatin knockout mice (35) and calpastatin overexpressing transgenic mice (30) with mice overexpressing the human mutated [A30P]aSyn under control of the Thy-1 promoter (37) . Here, we demonstrate for the first time that the overexpression of calpastatin leads to a reduction in truncated as well as aggregated aSyn and to synaptic impairment in vivo. These data indicate that calpain may be an attractive candidate target for therapeutical intervention in PD.
RESULTS

Cleavage pattern of [WT]aSyn and [A30P]aSyn in vitro
Calpain is known to recognize motifs between conformational domains, therefore resulting in a distinct cleavage pattern of soluble and fibrillized aSyn (32, 33) . Since the A30P mutation of aSyn is known to increase its propensity to aggregate (39 -41), we first determined whether [WT]aSyn and [A30P]aSyn display the same calpain cleavage pattern using a calpain 1 in vitro cleavage assay. Recombinant soluble as well as fibrillar human aSyn was incubated with recombinant calpain 1 and calcium (3 mM) for up to 30 min. Two different antibodies directed against the N-or C-terminus of aSyn (Fig. 1A) were used to identify the calpain 1 cleavage pattern of aSyn. Both, [WT]aSyn and [A30P]aSyn, were cleaved equally and showed a similar fragment pattern. However, the cleavage pattern between soluble and fibrillar aSyn showed clear differences. Overall, the soluble C-terminal aSyn fragments ( Fig. 1B ; i) were much smaller than the fibrillar C-terminal fragments ( Fig. 1B; iii) , whereas the N-terminal aSyn fragments ( Fig. 1B; ii, iv) revealed comparable sizes. Although most of the higher-molecular fibrillized [A30P]aSyn structures were reduced after calpain digestion, a remaining strong signal at the size of 25-37 kDa was detected after 30 min that may indicate formation of dimeric aSyn species. These differences in higher molecular structures between the recombinant [A30P]aSyn and [WT]aSyn are most likely due to the increased propensity of the A30P mutation to form oligomers, which was observed both ex vitro (7, 42) and in PD (43) . In particular, the 35-37 kDa species was previously detected as an SDS -PAGE resistant dimer (42 -45) . Analytical ultracentrifugation measurement confirmed the presence of dimeric aSyn representing 2.2% of total aSyn (Supplementary Material, Fig. S1A and B). Its strong detection level might be overestimated by an antibody preference toward accessible epitopes, as previously described (42) . The incubation with the calpain inhibitor ALLN sufficiently prevented fragmentation of both [WT]aSyn and [A30P]aSyn and thus confirmed the specificity of the calpain-derived fragments of aSyn (see also Supplementary Material, Fig. S1C ). Thus, our results suggest that mutant soluble and fibrillized [A30P]aSyn is readily cleaved by calpain 1, leading to accumulation of both N-and C-terminally truncated species, the latter may potentiate its conversion into dimeric structures.
Generation of SynCAST(2) and SynCAST(1) mice
To investigate the role of calpain in PD-associated aggregation and neuropathology in vivo, we generated SynCAST(+) double transgenic mice overexpressing human mutated [A30P]aSyn (37) as well as human calpastatin, the only natural inhibitor of calpain (30) Fig. 2A) . Calpain activation was additionally measured by an antibody against alpha-spectrin, a well-known substrate for calpain that yields to a specific 145 kDa breakdown product of alpha-spectrin ( Fig. 2A; 44) . Overexpression of human calpastatin (cast(+/+), SynCAST(+)) leads to a significant reduction in the calpain 1 expression level compared with SynCAST(2) mice ( Fig. 2A and B) . It also revealed a significant decreased ratio of 145 kDa calpain-cleaved and 240 kDa uncleaved alpha-spectrin when compared with [A30P]aSyn and SynCAST(2) ( Fig. 2A and C) . Interestingly, we found an increase in the breakdown product of calpain-cleaved spectrin, an indicator of overall calpain activity in [A30P]aSyn single Figure 2 . Expression of calpain 1 is changed and decreases calpain-mediated spectrin breakdown product in a mouse model of Parkinson's disease upon calpastatin overexpression. (A) Lysates of the brain stem (n ¼ 3) were used for western blot analysis. Decreased ratio of autocleaved calpain 1 (activated; 75 kDa) to the fulllength form (latent; 80 kDa) is observed upon overexpression of human calpastatin (SynCAST(+), cast(+/+)), whereas the knockout of calpastatin (SynCAST(2), cast(2/2)) leads to an increased ratio. The activity of calpain was measured using an antibody against alpha-spectrin, a well-known substrate, and its breakdown product (145 kDa). Calpain-mediated spectrin breakdown product was dramatically decreased in the brain stem of animals overexpressing calpastatin, especially when aSyn was overexpressed. (B and C) Quantification of the expression level of calpain 1 and the ratio of 145 kDa calpain-cleaved and 240 kDa uncleaved alpha-spectrin was done by densitometric measurements. The (#) sign represents the significance compared with [A30P]aSyn, and the dollar sign ($) compared with SynCAST(2). Error bars represent mean + SEM. Statistical significance was evaluated by one-way ANOVA where ( * * ) indicates P , 0.01. (D) Staining of the brain stem with an antibody specific for both, activated and inactivated calpain 1. Immunohistochemistry revealed a punctuated staining for calpain 1 after knockout of calpastatin as well as overexpressing human [A30P]aSyn, whereas the pattern is increased after knockout. Mice overexpressing calpastatin and wild-type mice displayed a weak and homogeneous staining of calpain 1. Scale bar ¼ 50 mm. transgenic mice, further elevated by its overexpression on calpastatin-deficient background ( Fig. 2A and C) . Thus, our data may reflect a tendency of increased calpain activity in [A30P]aSyn single transgenic mice in vivo that is further triggered by its overexpression on calpastatin-deficient background. We also performed immunohistochemical analysis for calpain 1 (Fig. 2D ). Its expression pattern differed between the various mouse lines used: knockout of calpastatin in SynCAST(2) as well as overexpression of [A30P]aSyn showed a pronounced punctuated calpain1 immunoreactivity and was detected both in soma and the neuropil, whereas SynCAST(+) mice overexpressing calpastatin and wild-type mice exhibited a more weak and homogenous expression pattern (Fig. 2D) .
Overexpression of CAST leads to reduced fragmentation of aSyn
To analyze the cleavage pattern of aSyn by calpain in vivo, we performed western blot analysis of lysates of the brain stem of young (3 months; n ¼ 3) and aged (19 months; n ¼ 3) mice. The antibody panSyn targets the aSyn N-terminus and recognizes both, human and murine aSyn, whereas the antibody 15G7 detects only human aSyn at its C-terminus ( Fig. 1 A) . Thus, the N-terminal antibody recognizes C-terminally cleaved aSyn (CT-aSyn), whereas 15G7 detects the N-terminally cleaved fragments of aSyn (NT-aSyn). We did not detect a decrease of full-length aSyn (Fig. 3A, * human/murine, # human) over the time. Neither overexpression nor knockout of calpastatin revealed significant differences of the CT-aSyn 1 fragment (Fig. 3B) . However, the amount of the smaller soluble CT-aSyn 2 fragments, which were also detected via calpain digestion of purified recombinant [A30P]aSyn (Fig. 3A , left panel), were less abundant in calpastatin overexpressing mice when compared with SynCAST(2) and [A30P]aSyn. Moreover, the amount of the CT-aSyn 2 fragments strongly increased with age in [A30P] aSyn and SynCAST(2), whereas its low level remained unchanged in SynCAST(+) mice (Fig. 3B) . The NT-aSyn 1 fragments were almost stable over the time; however, a significant reduction was observed by calpastatin co-overexpression in SynCAST(+) (Fig. 3B ). In summary, the fragmentation of aSyn is reduced by the overexpression of calpastatin, associating with activation of calpain in SynCAST(2) mice and thus provides clear evidence that calpain is involved in truncation of aSyn in vivo.
Mass spectrometric identification of aSyn truncations in SynCAST(2) and SynCAST(1) mice
The mass spectrometric nanoLCESI-MS/MS experiments enabled unambiguous identification of 19 truncated forms of aSyn (Table 1 , Fig. 3C ). For the correct assignment of the aSyn truncation, we used a multistage strategy with three control instances. Hereto, we used (i) a database with all possible forms of aSyn truncations, combined with (ii) an additional search against a database containing all proteins known to be expressed in aged (19 months) mice to exclude false positive identifications for individual fragment ion spectra, and (iii) the comparison of the generated in vivo data with fragment ion analysis on recombinant [A30P]aSyn.
Using this strategy, we identified that the amphipathic repeat region of aSyn was affected by seven truncations. Six of them occurred within the N-terminal domain yielding protein fragments starting with amino acids 12, 14-17 and 50, and 1 was a C-terminal fragment ending at position 56. The hydrophobic NAC region was affected more often as indicated by nine N-terminal and three C-terminal fragments of the protein cleaved between amino acids 66 and 94. Presumable due to the enhanced calpain activity, we found marked elevations of protein fragmentation after amino acids 67 and 79-83 for the SynCAST(2) mice. Proteolysis of the acidic part was not detectable by this mass spectrometric setup in the investigated in vivo mouse models. It was only detectable with our quality control approach using recombinant [A30P]aSyn after tryptic digests of the previously in vitro calpain 1 cleaved protein.
Overexpression of CAST leads to a decreased number of cellular inclusions and prevents gliosis
To verify the effect of calpastatin modulation and thus calpain activation in SynCAST(2) and cast(2/2), as well as calpain inactivation in SynCAST(+) and cast(+/+) single transgenic mice on protein aggregation, we performed sequential protein extraction of the brain stem to detect insoluble aSyn by western blotting. We found a clear reduction in higher molecular weight immunosignals of aggregated aSyn in SynCAST(+) mice (Fig. 4A) . We also stained brain sections with Thioflavin S ( Fig. 4C; a-d) , an amyloid dye that binds beta-sheet-rich amyloid structures (arrows). Since aggregated aSyn is PK resistant, we also digested slices with PK prior immunohistochemical staining with an antibody specific to human aSyn, thereby monitoring inclusions ( Fig. 4C ; e-l; arrowhead). Measuring the aggregate load revealed that the inactivation of calpain in SynCAST(+) leads to a reduced aggregation (Fig. 4D-G) . Both, the %-area positive for Thioflavin S (Fig. 4D ) and human aSyn (Fig. 4E) , as well as the cellular inclusions (%) positive for Thioflavin S (Fig. 4F ) and human aSyn (Fig. 4G) were significantly decreased by co-overexpression of calpastatin in SynCAST(+) mice.
To confirm that calpain is indeed playing a role in the cleavage of aSyn in our genetically modified mouse models of PD, we used an antibody specific for human calpain-cleaved aSyn (SYN105, 42) in immunohistochemistry after PK digestion. The SYN105 antibody, kindly provided by Dr Masliah (University of California, San Diego, USA), has a strong preference to calpain-cleaved aSyn at amino acids 122 (Fig. 1A) (46, 47) . SYN105 did not detect aggregates in SynCAST(+) mice at all, but showed positive aggregates in SynCAST(2) as well as in [A30P]aSyn mice ( Fig. 4C ; m-p). These data indicate that calpain is an important factor that promotes cleavage and aggregation of aSyn. Furthermore, we showed for the first time that calpain is already activated and cleaving aSyn in [A30P]aSyn single transgenic mice. Associated with reduced calpain activation, we also found a remarkable reduction in activated astrocytes in the brain stem of the SynCAST(+) compared with [A30P]aSyn and SynCAST(2) mice, as shown by the reduced levels of the astrocytic marker GFAP (Fig. 5) . However, using TUNEL and toluidine staining, we found no indication for enhanced cell death in our models (unpublished data).
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Overexpression of CAST ameliorates the CAST-depletion-dependent synaptic pathology
The presence of aSyn misfolding and truncations, known to interfere with SNARE complex assembly (48) , prompted us to analyze synaptic proteins implicated in the vesicle cycle. In addition, calpains have not only been associated with neurodegeneration but are also involved in synaptic dysfunction (27, 30, 31, 49) . To evaluate the modulatory effect of calpain on the expression level of synaptic markers, we isolated the synaptosomes with the Syn-PER Synaptic Protein Extraction Reagent (Thermo Scientific). The total level of synaptic vesicle proteins synaptophysin, synapsin Ia/b and NSF, the latter involved in synaptic vesicle fusion, showed a significant reduction in SynCAST(2) compared with SynCAST(+) mice (Fig. 6A-D) . The significant alteration of synapsin I (Fig. 6A and C) and NSF levels ( (30), leads to a reduction in the truncation of aSyn and reduced protein aggregation in SynCAST(+) mice, respectively.
In an in vitro assay, we provide evidence that [WT]aSyn and [A30P]aSyn have the same cleavage pattern and that only the fibrillation of aSyn has an influence on the cleavage pattern, which was detected by western blot analysis (Fig. 1B) . These findings were similar to previously published in vitro studies (33) .
As calpastatin acts as a buffering mechanism against involuntary protein cleavage during calpain activation (52) modulating constitutive calpain activation in vivo (30), we generated two contrary mouse models to investigate the long-term impact of calpain cleavage of aSyn as a model of the pathogenesis of PD. We either inactivated or activated calpain in a PD mouse model overexpressing human [A30P]aSyn (37) via overexpressing human calpastatin (30) or through the depletion of the mouse-endogenous calpastatin (35) .
The studied single transgenic [A30P]aSyn mouse is a wellestablished model for a-synucleinopathy and was shown to form somatodendritic accumulations of insoluble aSyn through the brain and spinal cord (37) . Upon aging, overexpressed human aSyn achieves a fibrillar amyloid conformation, observed by Thioflavin S and PK-resistant aggregated aSyn, that were mainly present in brain stem nuclei (36, 38) . For that reason, our study focused on the impact of calpain on the pathogenesis of a-synucleinopathy in the brain stem.
We were able to modify the expression level of calpain 1 in both SynCAST(+) and SynCAST(2) mice demonstrated by immunoblots with an antibody that is targeting the autocleaved (75 kDa) as well as full-length (80 kDa) calpain 1 ( Fig. 2A and  B) . Thus, the overexpression of calpastatin exhibits a reduced expression of activated calpain 1, whereas mice on a calpastatindeficient background revealed increased protein levels of activated calpain 1 ( Fig. 2A and B ). An indicator of the activity of calpain in total is alpha-spectrin, a well-known substrate of calpain whose proteolysis results in a 145 kDa breakdown product that has been used previously as a quantitative measurement (30, 53) . Indeed, the ratio of the 145 kDa calpain-cleaved and 240 kDa uncleaved spectrin substantiated a higher activity of calpain in SynCAST(2) mice, whereas the activity of calpain is significantly decreased in the SynCAST(+) animals Fig. 2A and C) . The correlation between the calpain expression level and activity is in agreement with a previous study on the impact of the calpain activation in a transgenic Alzheimer mouse model overexpressing calpastatin (29) . Moreover, it was shown that calpain 1 is responsible for the C-terminally (amino acids 122) cleavage of aSyn that results in the formation of toxic fragments (3, 16, 32) .
To investigate the impact of calpain on the proteolysis of aSyn in young and old animals, we performed immunoblot analysis and combined it to the use of two antibodies that permitted the detection C-terminally as well as N-terminally truncated aSyn species. The cleavage pattern was not age-dependent (Fig. 3A) , but the level of the fragmented aSyn increased over the detected time period (Fig. 3A and B) . In addition, SynCAST(+) mice displayed fewer fragments: N-terminal truncations were completely diminished in SynCAST(+) mice and a selective C-terminal truncated fragment ( 9 kDa) was not detectable anymore (Fig. 3) . These data were confirmed by mass spectrometric analysis that allowed the identification of aSyn truncations within the N-terminus and NAC region, respectively (Table 1) . However, cleavage in the C-terminal acidic region was not detected (Fig. 3C) . Previous experiments on recombinant aSyn also showed that peptides cleaved after amino acids 113, 115, 119 or 122 were identifiable by mass spectrometry, but their ionization behavior is not well understood (54) . These C-terminal peptides lack alkaline amino acids which act as a proton catcher for an efficient ionization process and it is most likely that this has an effect on their underrepresentation in the complex peptide mixture we used in this study.
In support of previous reports which indicated that the calpastatin -calpain system is associated with protein aggregation in neurodegenerative diseases (27) (28) (29) 55) , we found a decreased aggregation load in SynCAST(+) compared with SynCAST(2) and single transgenic [A30P]aSyn mice by monitoring aggregates by the use of Thioflavin S, PK and detection of high molecular aSyn in the insoluble fraction (Fig. 4) . Furthermore, we did not detect aggregates positive for calpain-cleaved aSyn in SynCAST(+) mice using an antibody targeting a major calpain cleavage site in human aSyn at amino acids 122 (32, 46) . All these findings are in line with previous in vitro data showing that calpain is cleaving soluble aSyn in particular in its N-terminal moiety, while fibrillar aSyn is mainly cleaved within its C-terminus (33) and is associated to a stronger aggregation phenotype (3, 15, 16, 18, 46, 51) . In addition, the tendentiously increased calpain activity via overexpression of human [A30P]aSyn was further triggered by calpastatin depletion, as evidenced by calpain autocleavage, spectrin breakdown and the specific antibody SYN105 immunoreactivity. This may be explained by the fact that calpain is activated by an increased intracellular calcium concentration as a response to the overexpression of aSyn leading to oligomerization at synaptic membranes associating with an increased calcium influx (33, (56) (57) (58) . Both, the calcium-dependent protease calpain and aSyn, are localized at presynaptic terminals (33) . Previous studies revealed that the overexpression of aSyn inhibits the release of neurotransmitters (59) , which refer to the notion that aSyn aggregate-related synaptic dysfunctions cause neurodegeneration (60) . Furthermore, N-terminal truncation and the A30P mutation are known to decrease synaptic targeting, while C-terminal truncation additionally increased the aggregation-dependent neurotoxicity in PD models (48). In addition, the level of GFAP, an indicator of astrogliosis and a classical marker for neuronal injury, associated with synaptic impairment in PD models (19, 47, 61, 62) , is also increased after the activation of calpain 1 in injured spinal cord and prion-infected mice (63, 64) . Recently, it was also shown that the passive immunization with a C-terminal antibody reduced the accumulation of calpain-cleaved aSyn in axons and synapses (55) . Furthermore, overexpression of calpastatin as well as the passive immunization with an antibody against the C-terminus of aSyn (amino acids 118-126) prevents synapse loss and astrogliosis (29, 30, 55) . Since we observed a calpaindependent modulation of these markers, in particular the aSyn truncations (Fig. 4) , reactive astrogliosis (Fig. 5) and the CASTdependent depletion of synaptic markers (Fig. 6) , were ameliorated in double transgenic SynCAST(+) mice, our data support the assumption that the calpain-calpastatin system plays an important role in aggregation and synaptic pathology in the present PD model. Alteration of synaptic marker between single transgenic cast (+/+) and cast (2/2) knockout mice may point toward a primary role of calpain in the synaptic vesicle cycle. Interestingly, cast (2/2) mice showed a significant depletion of synapsin I when compared with cast (+/+) and non-transgenic controls. Recently, Easley-Neal et al. (65) described a negative role of p25-hyperactivated cyclin-dependent kinase 5 (Cdk 5) related recruitment of synapsin I to the synapse. Therefore, the previously observed calpain-dependent aberrant activation of Cdk 5 and its known inhibition in CAST mice (66) may explain the observed alteration in synapsin I level. The additionally detected specific reduction in synaptophysin in SynCAST(2) mice, however, may relate to an adverse synergistic effect of A30P aSyn and calpain on synaptic integrity.
In summary, we show that aSyn is proteolytically cleaved by calpain in vivo and that a decreased cleavage of aSyn via calpain inhibition results not only reduced the aggregation load, but also preserved synaptic integrity and diminished astrocytosis. Therefore, the present study support a crucial role for abnormal calpain activation as well as subsequent increased truncation of aSyn in the pathogenesis of PD and offer an interesting target for prospective therapeutic approaches of synucleinopathies.
MATERIALS AND METHODS
Calpain cleavage of a-Synuclein in vitro
Recombinant wild-type ([WT]aSyn) and A30P aSyn ([A30P]aSyn) were expressed in Escherichia coli strain BL21 (DE3; Stratagene) and purified as described (67) . Soluble WT or [A30P]aSyn were assembled into fibrils in assembly buffer (50 mM Tris-HCl, pH 7.5, 150 mM KCl) at 378C, following continuous shaking at 600 rpm in an Eppendorf Thermomixer (Hamburg, Germany). Assembly was monitored using Thioflavin T binding and the fibrillar nature of the assembly was assessed after adsorption on carbon-coated 200-mesh grids, staining with 1% uranyl acetate and imaging by electron microscopy (Jeol 1400 transmission electron microscope; JEOL, Peabody, MA, USA).
The calpain cleavage assay was performed with minor changes as described previously (28, 32, 33 containing 1000 ng calpain 1 at 378C for 30 min. To verify the specific cleavage of aSyn by calpain, we utilized an inhibitor specific for calpain (ALLN, Sigma). The reaction was stopped by the addition of 5× Laemmli buffer and denaturation of samples at 958C before western blot analysis.
Analytical ultracentrifugation
Sedimentation velocity measurements were carried out using an Optima XL-A ultracentrifuge (Beckman Coulter, Fullerton, CA, USA) equipped with UV-visible detection system using an AN60-Ti four-hole rotor and cells with two-channel 12 mm path length centerpieces. Soluble a-syn, 400 ml in 50 mM TrisHCl, pH 7.5, 150 mM KCl, was spun at 50000 rpm (182000g) and 158C. Sample displacement profiles were obtained by recording the absorbance at 280 nm every 5 min. Sedimentation coefficient continuous c(s) distribution was determined using the software Sedfit (68) . The partial specific volume (0.7305 ml/g), the buffer viscosity (1.1534 cP) and density (1.00765 g/ml) were calculated with the software Sednterp. The sedimentation coefficient values were corrected to s 20,w (standard solvent conditions in water at 208C). Calpastatin-depleted mice were identified by PCR with specific primers as described previously (35) Material, Fig. S3 ).
Protein extraction
Dissected mouse brain stems (n ¼ 3) at the age of 3 and 19 months were homogenized either in TES (50 mM Tris, pH 7.5, 2 mM EDTA, 100 mM NaCl) or in TBS (pH 7.5, 10 mM Tris, 150 mM NaCl) buffer, supplemented with a cocktail of protease inhibitors (Complete; Roche Applied Science). Samples prepared with TES buffer were centrifuged at full speed for two times for 15 min. To analyze differences of the fragment pattern of soluble aSyn and the insoluble fraction between the six lines, proteins were sequentially extracted as described previously (69, 70) . Briefly, brain stem was homogenized in TBS buffer, spun for 30 min at 120 000 g at 48C and the supernatant representing the cytoplasmic fraction was collected. After three following steps, insoluble proteins were solubilized in 8 M urea plus 5% SDS. Owing to limited sample size, urea specimens of n ¼ 3 animals were pooled to analyze insolubility of aSyn in brain stem region.
Synaptic protein extraction
To measure the expression level of different synaptic markers in the brain stem of aged mice (n ¼ 3), we used the Syn-PER Synaptic Protein Extraction Reagent (Thermo Scientific) as described in the manual.
Immunoblot analysis
For immunoblot analysis, proteins were loaded on a SDS -PAGE and blotted afterward onto nitrocellulose membranes (Whatman). After blocking, the following primary antibodies were used: rabbit anti-aSyn panSyn (human/mouse; 1:100; Dianova) and rat anti-aSyn 15G7 (human; 1:50; Enzo Life Science), mouse anti-aSyn MC42 (1:3000; BD Transduction Laboratories), rabbit anti-calpain-1 Large Subunit (1:1000; Thermo Scientific), mouse anti-alpha-spectrin (1:500; Millipore), mouse anti-synaptophysin (1:500; Millipore), rabbit anti-synapsin 1/a/b (1:1000; Santa Cruz), rabbit anti-NSF (1:1000; Cell Signaling) and mouse anti-b-actin (1:10.000; Sigma). Secondary antibodies were either coupled to horseradish peroxidase (GE Healthcare) and diluted 1:3000 or labeled with a fluorescent dye (Li-Cor) and diluted 1:5000. Results were obtained for three animals per line each.
Mass spectrometric identification of aSyn truncations
Thirty micrograms of cytosolic whole brain stem protein lysates were electrophoresed via SDS -PAGE. After transfer, gel was silver stained, imaged (unpublished data) and sliced horizontally between 8 and 19 kDa. For silver staining, we used a method according to Jungblut and Seifert (71) with slight modifications to ensure mass spectrometric compatibility. Hereto, we used ethanol instead of methanol during fixation and incubation and we omitted glutaraldehyde in the incubation solution as well as formaldehyde in the silver nitrate solution. Gel slices were destained, rinsed and consecutively used for an overnight in-gel digest with trypsin. Peptides were extracted and after an amino acid analysis to determine the peptide concentration, 200 ng of the extracts were used for nanoLC-ESI-MS/MS protein identification experiments. Hereto, peptides were separated on an UltiMate 3000 RSLCnano HPLC system (Dionex, Sunnyvale, CA, USA). After loading the samples on a trap column (300 mm × 0.5 cm, particle size: 5 mm, pore size: 100 Å ; Dionex) and washing for 5 min with 0.1% TFA, the peptides were separated on an analytical C18 column (75 mm × 25 cm, particle size: 2 mm, pore size: 100 Å ; Dionex). The following solvents were used for separating the peptides with a flow rate of 400 nl/min: 0.1% formic acid (A); 84% ACN, 0.1% formic acid (B); HPLC-gradient: 4 -40% B in 44 min, 40-95% B within 3 min and held at 95% B for further 5 min before the system was equilibrated for the next analysis. The HPLC system was connected to a nanoelectrospray ionization source (Thermo Fisher Scientific, USA) and ESI-MS/MS experiments were performed on a VelosPro (Thermo Fisher Scientific) ion trap mass spectrometer. MS spectra were scanned between 300 and 2000 m/z. The five most intensive ions (charge . 1) were selected for additional MS/MS fragmentation in the ion trap. Afterward, these ions were set on a dynamic exclusion list for 35 s to enable the analysis of ions with lower abundances. Fragments were generated by collision-induced dissociation on isolated ions with a collision energy of 35% and an activation time of 10 ms. The nano-LC-MS/MS data were transformed into MGF files for database searches with the Mascotw search algorithm (Matrix Science, London, UK, version 2.2.0), using a peptide mass tolerance of 0.4 Da and a fragment mass tolerance of 0.5 Da. For the protein identification, the enzyme settings were set on "trypsin" and up to two possible missed cleavage sites were considered for the database searches, as well as the following variable modifications: acetylation of protein N-terminus and oxidation of methionine. All data were
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searched against the Uniprot/Sprot database using a decoy strategy to exclude false positive identifications and additionally an in-house database consisting of the yeast proteome and all possible N-terminal and C-terminal truncations of aSyn was used to identify potential calpain cleavage products of this protein.
Only peptide identifications with a Mascot score of .40 were considered for the analysis. Furthermore, the validity of the truncation corresponding peptide identifications was assigned by fragment ion spectra generated after tryptic digests of previously in vitro calpain cleaved recombinant [A30P]aSyn. For the comparison of truncated aSyn in the brain of the different mouse models and to generate normalized precursor ion intensities adjusting differences in individual analysis, the nano-LC-MS/MS data were analyzed with the Progenesis LC-MS (V. 4.0) software.
Neuropathological analysis by Thioflavin S, PK and immunohistochemistry
Briefly, fixed brain tissue was incubated overnight in 30% sucrose and frozen at 2208C for 24 h. Brains were then embedded in tissue freezing medium (Leica Microsystems GmbH) and 7 mm sections were made with the cryomicrotome (JUNG CM3000, Leica). Beta-pleated protein conformations were labeled by incubating the brain sections with the amyloid dye Thioflavin S (0.01% in H 2 O; Sigma) for 5 min and washed three times for 1 min in 70% ethanol. PK digestion (Sigma) was carried out as described (72) and was followed by previously described immunohistochemistry (73) . Briefly, after digestion with PK slices was incubated over night with the primary antibodies at following dilutions: rat anti-aSyn 15G7 (human) (1:25; 36) and SYN105 (1:200; 43). The next day, sections were preceded with the respective biotinylated secondary antibodies (1:200, Vector Laboratories) and visualized by using the Avidin-biotin (ABC) kit (Vector Laboratories) with diaminobenzidine tetrahydrochloride (DAB; Sigma) as the chromogen. For GFAP (1:100, Dako) and calpain 1 (1:250; Abcam), slices were not digested with PK and incubated with fluorescence-coupled antibody rabbit anti-Cy2 (1:250; Dianova). Cell death in the brain stem of 19 months old mice was analyzed with a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay kit conjugated with TMR red (Roche Applied Science) as described in the manual.
Statistical analysis
Aggregates and neurodegenerative cells were quantified by acquiring 12 fields of the brain stem (Fig. 4B ) with a 20× objective using an Axioplan 2 imaging microscope (Zeiss) equipped with an AxioCam HR color digital camera (Zeiss). For each genotype, three independent mice were used and two slices were analyzed each. The collected images were analyzed with Image J. Therefore, images were converted to an 8-bit format, an intensity threshold was set and the %-area positive for Thioflavin S, PK-resistant aSyn, GFAP and TUNEL was analyzed. Cellular inclusions positive for Thioflavin S and PK-resistant aSyn were counted manual by the Image J cell counter. Data were then analyzed by using GraphPad Prism by an one-way ANOVA with a significance threshold of * P , 0.05. All results are presented as mean + SEM.
